findmyKOL

Shari Lipner

Basic profile

Cornell University

ORCIDNPI
RegionNew York, NY · NortheastSpecialtyDermatologyFocusDermatology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Shari Lipner is a Dermatology physician affiliated with Cornell University. OpenAlex indexes 884 publications with 5,953 citations (h-index 36); ClinicalTrials.gov lists 11 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
884publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,953citations

Total citations across indexed works.

36h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1305 York Ave
New York, NY 100215663

Telephone

646-962-3376

Registry record last updated 9 Dec 2011.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    43.9%
    Corticosteroid20.8%
    Triamcinolone Acetonide54%Triamcinolone acetonide30%Fluocinolone Acetonide17%
    Part D + Part B<11 patients
    alpha-Hydroxy Acid11.3%
    Ammonium Lactate100%
    Part D62 patients

    + 4 more classes in this area

  • Sensory organs

    17.2%
    Corticosteroid14%
    Clobetasol Propionate55%Hydrocortisone45%
    Part D31 patients
    Aminoglycoside Antibacterial3.2%
    Gentamicin Sulfate100%
    Part D14 patients
  • Anti-infectives

    12.8%
    Azole Antifungal5.9%
    Ketoconazole100%
    Part D23 patients
    Nitroimidazole Antimicrobial2.5%
    Metronidazole100%
    Part D12 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”